These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 26874511

  • 1. Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial.
    Jo YI, Na HY, Moon JY, Han SW, Yang DH, Lee SH, Park HC, Choi HY, Lim SD, Kie JH, Lee YK, Shin SK.
    Korean J Intern Med; 2016 Mar; 31(2):335-43. PubMed ID: 26874511
    [Abstract] [Full Text] [Related]

  • 2. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [Abstract] [Full Text] [Related]

  • 3. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [Abstract] [Full Text] [Related]

  • 4. Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.
    Yu MY, Kim YC, Koo HS, Chin HJ.
    PLoS One; 2017 May; 12(11):e0188375. PubMed ID: 29155873
    [Abstract] [Full Text] [Related]

  • 5. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.
    Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S.
    Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837
    [Abstract] [Full Text] [Related]

  • 6. Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension.
    Lou-Meda R, Stiller B, Antonio ZL, Zielinska E, Yap HK, Kang HG, Tan M, Glazer RD, Valentin MA, Wang L.
    Pediatr Nephrol; 2019 Mar; 34(3):495-506. PubMed ID: 30397789
    [Abstract] [Full Text] [Related]

  • 7. Low-dose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy.
    Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.
    Hypertens Res; 2008 Sep; 31(9):1711-7. PubMed ID: 18971549
    [Abstract] [Full Text] [Related]

  • 8. Antiproteinuric effect of olmesartan in patients with IgA nephropathy.
    Tomino Y, Kawamura T, Kimura K, Endoh M, Hosoya T, Horikoshi S, Utsunomiya Y, Yasuda T, Toyoda M, Tsuge T, Kaneko K.
    J Nephrol; 2009 Sep; 22(2):224-31. PubMed ID: 19384840
    [Abstract] [Full Text] [Related]

  • 9. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007 Sep; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 10. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of valsartan plus activated vitamin D versus valsartan alone in IgA nephropathy with moderate proteinuria.
    Xiaowei L, Bo W, Li L, Peng Z.
    Int Urol Nephrol; 2020 Jan; 52(1):129-136. PubMed ID: 31768803
    [Abstract] [Full Text] [Related]

  • 12. Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers.
    Choi S, Lee D, Jeong KH, Moon JY, Lee SH, Lee TW, Ihm CG.
    Clin Nephrol; 2009 Nov; 72(5):353-9. PubMed ID: 19863877
    [Abstract] [Full Text] [Related]

  • 13. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.
    Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H.
    Am J Kidney Dis; 2019 Jul; 74(1):15-22. PubMed ID: 30922594
    [Abstract] [Full Text] [Related]

  • 14. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
    Gao R, Wu W, Wen Y, Li X.
    Int Urol Nephrol; 2017 Jul; 49(7):1233-1241. PubMed ID: 28349446
    [Abstract] [Full Text] [Related]

  • 15. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT, Lau YK, Wong KS, Chiang GS.
    Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
    [Abstract] [Full Text] [Related]

  • 16. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
    Campbell R, Sangalli F, Perticucci E, Aros C, Viscarra C, Perna A, Remuzzi A, Bertocchi F, Fagiani L, Remuzzi G, Ruggenenti P.
    Kidney Int; 2003 Mar; 63(3):1094-103. PubMed ID: 12631093
    [Abstract] [Full Text] [Related]

  • 17. Probucol combined with valsartan in immunoglobulin A nephropathy: a multi-centre, open labelled, randomized controlled study.
    Ye Z, Zhang L, Xu L, Shi W, Hu H, Shi X, Zhong W, Hou S, Yan H, Zhang B, Xia Y, Wang W, Feng Z, Wang L, Liang Y.
    Nephrology (Carlton); 2014 Jan; 19(1):40-6. PubMed ID: 24191893
    [Abstract] [Full Text] [Related]

  • 18. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
    Horita Y, Taura K, Taguchi T, Furusu A, Kohno S.
    Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
    [Abstract] [Full Text] [Related]

  • 19. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
    Ishii T, Kawamura T, Tsuboi N, Ogura M, Utsunomiya Y, Hosoya T.
    Contrib Nephrol; 2007 Oct; 157():114-9. PubMed ID: 17495447
    [Abstract] [Full Text] [Related]

  • 20. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
    Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM.
    Trials; 2017 Apr 11; 18(1):170. PubMed ID: 28395659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.